GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » ROE %

Praxsyn (Praxsyn) ROE % : 167.49% (As of Sep. 2015)


View and export this data going back to 2007. Start your Free Trial

What is Praxsyn ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Praxsyn's annualized net income for the quarter that ended in Sep. 2015 was $11.88 Mil. Praxsyn's average Total Stockholders Equity over the quarter that ended in Sep. 2015 was $7.09 Mil. Therefore, Praxsyn's annualized ROE % for the quarter that ended in Sep. 2015 was 167.49%.

The historical rank and industry rank for Praxsyn's ROE % or its related term are showing as below:

PXYN's ROE % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.15
* Ranked among companies with meaningful ROE % only.

Praxsyn ROE % Historical Data

The historical data trend for Praxsyn's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn ROE % Chart

Praxsyn Annual Data
Trend Oct05 Oct06 Oct07 Oct08 Oct09 Dec10 Dec11 Dec12 Dec13 Dec14
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,668.42 - - Negative Equity -

Praxsyn Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Negative Equity -5.17 152.31 317.05 167.49

Competitive Comparison of Praxsyn's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Praxsyn's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Praxsyn's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Praxsyn's ROE % distribution charts can be found below:

* The bar in red indicates where Praxsyn's ROE % falls into.



Praxsyn ROE % Calculation

Praxsyn's annualized ROE % for the fiscal year that ended in Dec. 2014 is calculated as

ROE %=Net Income (A: Dec. 2014 )/( (Total Stockholders Equity (A: Dec. 2013 )+Total Stockholders Equity (A: Dec. 2014 ))/ count )
=-12.354/( (-4.629+1.632)/ 2 )
=-12.354/-1.4985
=N/A %

Praxsyn's annualized ROE % for the quarter that ended in Sep. 2015 is calculated as

ROE %=Net Income (Q: Sep. 2015 )/( (Total Stockholders Equity (Q: Jun. 2015 )+Total Stockholders Equity (Q: Sep. 2015 ))/ count )
=11.876/( (5.606+8.575)/ 2 )
=11.876/7.0905
=167.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2015) net income data. ROE % is displayed in the 30-year financial page.


Praxsyn  (GREY:PXYN) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2015 )
=Net Income/Total Stockholders Equity
=11.876/7.0905
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(11.876 / 81.716)*(81.716 / 31.9765)*(31.9765 / 7.0905)
=Net Margin %*Asset Turnover*Equity Multiplier
=14.53 %*2.5555*4.5098
=ROA %*Equity Multiplier
=37.13 %*4.5098
=167.49 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2015 )
=Net Income/Total Stockholders Equity
=11.876/7.0905
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (11.876 / 22.444) * (22.444 / 21.624) * (21.624 / 81.716) * (81.716 / 31.9765) * (31.9765 / 7.0905)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.5291 * 1.0379 * 26.46 % * 2.5555 * 4.5098
=167.49 %

Note: The net income data used here is four times the quarterly (Sep. 2015) net income data. The Revenue data used here is four times the quarterly (Sep. 2015) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Praxsyn ROE % Related Terms

Thank you for viewing the detailed overview of Praxsyn's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Praxsyn (Praxsyn) Business Description

Traded in Other Exchanges
N/A
Address
61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101
Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.

Praxsyn (Praxsyn) Headlines